《新股消息》深蓝科技(01950.HK)近下限定价0.52元 一手中签率30%
中国人工革化学品制造商深蓝科技(01950.HK)公布招股结果,最终发售价定为每股0.52元,为近下限定价(招股价介乎0.5元至0.6元)。公开发售录超购11.47倍,每手4,000股,一手中签率为30.01%。该股将於明日(3月12日)上市,智富为独家保荐人。
公司预计所得款项净额为8,470万元,当中60%用於在现有建德生产厂房附近兴建新生产厂房及购买新机器及设备;16.4%用於强化自动化系统;21.8%用於透过将现有研究院迁至现有建德生产厂房,以及委聘更多有经验的专家及工程师,和购入更多先进的研发设备及测试设备以增强研发能力;1.8%将用作一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.